Press release -

ConceptoMed obtains ISO 13485 certification

ConceptoMed is proud to announce that it successfully passed the ISO 13485 quality assurance audit, and was issued the international ISO 13485 certificate by SP, our Notified Body.

The ISO 13485 standard specifies requirements for a quality management system where an organization needs to demonstrate its ability to provide medical devices that consistently meet customer and regulatory requirements applicable to medical devices, certifying that the organization’s Quality Management System for Medical Devices responds to this rigorous standard for the design, development, and production of medical devices.

Achieving the International Organization for Standardization certification for our quality management system reflects our commitment to the development of innovative, safe and effective products for the global market’ commented Christian Mide, CEO of ConceptoMed.

Marit Martinsen, Head of Regulatory Affairs and Quality Assurance in ConceptoMed, stated that ‘the ISO 13485 certification illustrates ConceptoMeds strong commitment to quality and our ability to reach milestones crucial to the regulatory processes required for worldwide medical device commercialization’.

Obtaining the ISO 13485 certification is a testament to the professionalism, the rigor, and team spirit that prevails within our company’ indicated Christian Mide. ‘The achievement of this important objective is a key step toward the marketing and further development of the company’s products on the healthcare markets over the course of the coming years.

Related links

Topics

  • Business enterprise

Categories

  • iso13485
  • iso 13485

ConceptoMed AS is a rising medtech star serving the global market with innovative product categories and unique proprietary technology. We create smart medtech systems that empower healthcare professionals and improve patient care. Excellence through simplicity is our code. We are brave, curious and dedicated. We simply care.

Based in Norway, the team is continuously meeting milestones and expanding its activities for international growth. For more information on the company and career opportunities, see www.conceptomed.com and www.luerjack.com. Follow us on MyNewsdesk and LinkedIn.

Contacts

Related content

  • LUER-JACK APPROVED FOR SALE & MARKETING IN EUROPE (CE mark)

    LUER-JACK APPROVED FOR SALE & MARKETING IN EUROPE (CE mark) FIRST ORDERS OF LUER-JACK SHIPPING AFTER CE-MARK APPROVAL ConceptoMed today announced that the company has received CE Mark approval for the Luer-Jack® syringe, a new and innovative medical syringe. Luer-Jack® is now ready for the European market and other large markets, where the CE mark allows for market entry.

  • ConceptoMed named in Disrupt 100 - Index of Disruptive Businesses Worldwide

    ConceptoMed proudly announce being named in the Disrupt 100 - a bi-annual Tällt Ventures publication celebrating the businesses with the most potential to influence, change or create new global markets. ConceptoMed were selected from over 1 million global startups and corporate ventures and judged by a selection of global brands.

  • Luer-Jack high-volume production agreement with AB Euroform MediPharm, Sweden

    On the 28th of October 2016, ConceptoMed and AB Euroform MediPharm entered into an agreement for high-volume capacity manufacturing for Luer-Jack. Euroform MediPharm is a ISO 13485 certified long-term partner within development and production of polymer products for world class customers in Pharmaceutical and Medical Technology industries.

  • Luer-Jack secures Sterigenics Sterilization Services Agreement

    In December 2016, ConceptoMed have entered into important collaborations with suppliers of sterilization services (Sterigenics) and logistics & healthcare warehousing services (DSV Logistics) to secure the global strategy for ConceptoMed and Luer-Jack.

  • ConceptoMed named "Company of the Year 2016" of Norwegian Medtech Cluster

    On Thursday 8th of December 2016, ConceptoMed was named Company of the Year 2016 among approx 190 members of Oslo Medtech, a health technology cluster dedicated to accelerate and support the development of new medtech and eHealth products, services and innovative solutions for the Norwegian and global health care market.